Search form
Search
contact us
Navigation
home
boards
Jobs
job ratings
cp wire
medtech news
pharmagather
catering
advertise
whistleblower info
pharmaceutical fraud
medical device | DME fraud
clinical lab fraud
False Claims Act
Legal Help
login/register
You are here
Home
» Aegerion says FDA approves Juxtapid, a treatment for a rare high cholesterol disorder
Aegerion says FDA approves Juxtapid, a treatment for a rare high cholesterol disorder
Aegerion says FDA approves Juxtapid, a treatment for a rare high cholesterol disorder
Submitted by
admin
on December 24, 2012 - 10:30am
Source:
Yahoo/AP
News Tags:
lomitapide
Homozygous Familial Hypercholesterolemia
Juxtapid
Aegerion
FDA
Headline:
Aegerion says FDA approves Juxtapid, a treatment for a rare high cholesterol disorder
Do Not Allow Advertisers to Use My Personal information
